Casdin Capital, LLC - AVIDITY BIOSCIENCES INC ownership

AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 148 filers reported holding AVIDITY BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.4%.

Quarter-by-quarter ownership
Casdin Capital, LLC ownership history of AVIDITY BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$7,975,000
-15.4%
1,250,000
+47.1%
0.88%
+7.2%
Q2 2023$9,426,500
-27.8%
850,0000.0%0.82%
-23.3%
Q1 2023$13,047,500
-30.8%
850,0000.0%1.08%
-26.4%
Q4 2022$18,861,500850,0001.46%
Other shareholders
AVIDITY BIOSCIENCES INC shareholders Q4 2022
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,571,160$40,096,00020.10%
Aaron Wealth Advisors LLC 524,239$13,378,0004.90%
Octagon Capital Advisors LP 430,041$10,975,0003.80%
EcoR1 Capital, LLC 2,103,950$53,693,0002.89%
RTW INVESTMENTS, LP 3,995,000$101,952,0001.71%
ACUTA CAPITAL PARTNERS, LLC 246,200$6,283,0001.71%
Cormorant Asset Management, LP 2,464,547$62,895,0001.50%
Logos Global Management LP 671,454$17,136,0001.47%
Boxer Capital, LLC 1,121,327$28,616,0000.92%
HighVista Strategies LLC 26,665$680,0000.43%
View complete list of AVIDITY BIOSCIENCES INC shareholders